Papers

21

Total Citations

388

H-Index

12

About

Ravi Barod is a leading urologic surgeon and researcher whose work centers on advancing robotic kidney surgery and optimizing treatment for small renal masses. His major contributions span three key areas: refining robotic partial nephrectomy (RPN) techniques, pioneering robot-assisted kidney transplantation (RAKT), and establishing structured training protocols for robotic surgery. Barod’s impact is evident in his highly cited multicenter analyses, including a study of 1,791 RPN patients that identified risk factors for urinary fistula (73 citations) and the European Robotic Urology Section series on RAKT outcomes (69 citations). He has also led critical investigations into surgical approaches for complex cases, such as RPN in obese patients and salvage robotic surgery for local recurrence. Notably, Barod is the principal investigator of the NEST trial, a groundbreaking cohort-embedded randomized controlled trial comparing percutaneous cryoablation to RPN for small renal masses, addressing the critical need for high-level evidence in this field. His comprehensive training framework for robotic surgery has further shaped best practices, ensuring safe and effective adoption of these technologies. Through this work, Barod has become a pivotal figure in evidence-based, minimally invasive renal surgery.

Research Focus

Key Achievements

12
H-Index
21
Papers
388
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Urinary fistula after robot‐assisted partial nephrectomy: a multicentre analysis of 1 791 patients
73 citations · 2015
📈 Most Prolific Year: 2015 (3 Papers)
🤝 Key Collaborators: 160
🏛 Institutions: Henry Ford Hospital, Royal Free London NHS Foundation Trust, Henry Ford Health System, The Royal Free Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago